Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effects of Tetrahydrobiopterin on Blood Pressure

Trial Profile

Effects of Tetrahydrobiopterin on Blood Pressure

Completed
Phase of Trial: Phase 0

Latest Information Update: 15 Nov 2013

At a glance

  • Drugs Sapropterin (Primary)
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Jul 2012 Additional lead trial centre (American Heart Association) identified as reported by ClinicalTrials.gov record.
    • 09 Jul 2012 Actual initiation date (December 2004) added as reported by ClinicalTrials.gov record.
    • 15 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top